INDEMNITY AND INSURANCE COSTS During the financial year, Directors and Officers of the Company and its subsidiaries are covered under the Directors and Officers Liability Insurance Policy (“the Policy”) in respect of liabilities arising from acts committed in their respective capacity as, inter alia, Directors and Officers of the Group and of the Company subject to the terms of the Policy. The total amount of indemnity coverage and insurance premium paid for the Directors and certain Officers of the Company and of the Group were RM15,000,000 and RM50,468 respectively. ISSUE OF SHARES AND DEBENTURES During the financial year, the Company issued 315,633,132 new ordinary shares from private placements on 15 May 2024, 29 May 2024 and 6 June 2024 at the issue prices of RM0.3600, RM0.3616 and RM0.4001 per ordinary share, respectively, totalling to RM113,045,669. The new ordinary shares issued rank equally in all respects with the existing ordinary shares of the Company. There were no other changes in the issued and paid-up capital of the Company during the financial year. There were no debentures issued during the financial year. OPTIONS GRANTED OVER UNISSUED SHARES No options were granted to any person to take up unissued shares of the Company during the financial year apart from the issuance of options pursuant to the ESOS. EMPLOYEE SHARE OPTION SCHEME At an extraordinary general meeting held on 1 April 2021, the shareholders of the Company approved as follows: i) establishment of a new ESOS of up to 5% of the total number of issued shares of the Company (excluding treasury shares, if any) at any point in time over the duration of the new ESOS for the eligible directors and employees of the Company and its subsidiaries (excluding dormant subsidiaries); and ii) allocation of ESOS Options to the Directors of the Company. The options offered for the subscription of unissued ordinary shares, the exercise price and the number of share options exercisable at end of the reporting period are as follows: Number of options over ordinary shares At Forfeited/ At Date of offer Exercise price 1.1.2024 Granted Exercised Lapsed 31.12.2024 12 April 2021 RM0.755 10,968,250 - - (475,500) 10,492,750 19 May 2021 RM0.635 10,000,000 - - - 10,000,000 1 March 2022 RM1.032 29,791,990 - - (10,341,640) 19,450,350 1 March 2023 RM0.580 7,972,000 - - (1,744,800) 6,227,200 58,732,240 - - (12,561,940) 46,170,300 Details of ESOS granted to the Directors are disclosed in the Directors’ interests section of the financial statements. 114 Financial Statements DAGANG NeXCHANGE BERHAD Integrated Report 2024 DIRECTORS’ REPORT for the financial year ended 31 December 2024
RkJQdWJsaXNoZXIy NDgzMzc=